跳至主要内容
临床试验/NCT00326313
NCT00326313Unknown不适用

Clinical Outcome of Neonate With GBS Positive Culture-12 Year Retrospective Study

Sheba Medical Center0 个研究点目标入组 74 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
74

研究概览

简要总结

Streptococci group B (GBS) is a the major reason for morbidity and mortality in neonates. It can present as pneumonia ,meningitis or sepsis.The mortality today is 5-20% and even more in preterm babies.

During the past two decade, the introduction of protocols for prophylactic antibiotics for women with a high risk for GBS infection, have led to a decline of 65% in GBS cases(0.32 for 1000 live birth compared to 1.8 cases in 1000).The purpose of the study is to check the morbidity and mortality at Sheba medical center in the last 12 years in children with positive blood culture for GBS. We assume that in our hospital the morbidity and mortality is less then expected. If proven right, we would then check the reasons for that outcome considering the type and length of treatment and the different virulence of the streptococcus.

详细描述

This is a retrospective case control study. We will review from archive the charts of all the neonates with positive blood culture for GBS, reviewing the course and severity of their illness.

研究设计

研究类型
Observational

入排标准

年龄范围
0 Years 至 2 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • GBS positive blood culture neonate and preterm babies

排除标准

  • Congenital malformations

研究者

申办方类型
Other Gov

相似试验